Unknown

Dataset Information

0

Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.


ABSTRACT: Purpose: High-grade serous ovarian cancer (HGSOC) is an aggressive disease with few available targeted therapies. Despite high expression of estrogen receptor-alpha (ER?) in approximately 80% of HGSOC and some small but promising clinical trials of endocrine therapy, ER? has been understudied as a target in this disease. We sought to identify hormone-responsive, ER?-dependent HGSOC.Experimental Design: We characterized endocrine response in HGSOC cells across culture conditions [ two-dimensional (2D), three-dimensional (3D), forced suspension] and in patient-derived xenograft (PDX) explants, assessing proliferation and gene expression. Estrogen-regulated transcriptome data were overlapped with public datasets to develop a comprehensive panel of ER? target genes. Expression of this panel and ER? H-score were assessed in HGSOC samples from patients who received endocrine therapy. Time on endocrine therapy was used as a surrogate for clinical response.Results: Proliferation is ER?-regulated in HGSOC cells in vitro and in vivo, and is partly dependent on 3D context. Transcriptomic studies identified genes shared by cell lines and PDX explants as ER? targets. The selective ER? downregulator (SERD) fulvestrant is more effective than tamoxifen in blocking ER? action. ER? H-score is predictive of efficacy of endocrine therapy, and this prediction is further improved by inclusion of target gene expression, particularly IGFBP3Conclusions: Laboratory models corroborate intertumor heterogeneity of endocrine response in HGSOC but identify features associated with functional ER? and endocrine responsiveness. Assessing ER? function (e.g., IGFBP3 expression) in conjunction with H-score may help select patients who would benefit from endocrine therapy. Preclinical data suggest that SERDs might be more effective than tamoxifen. Clin Cancer Res; 23(14); 3802-12. ©2017 AACR.

SUBMITTER: Andersen CL 

PROVIDER: S-EPMC5503796 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.

Andersen Courtney L CL   Sikora Matthew J MJ   Boisen Michelle M MM   Ma Tianzhou T   Christie Alec A   Tseng George G   Park Yongseok Y   Luthra Soumya S   Chandran Uma U   Haluska Paul P   Mantia-Smaldone Gina M GM   Odunsi Kunle K   McLean Karen K   Lee Adrian V AV   Elishaev Esther E   Edwards Robert P RP   Oesterreich Steffi S  

Clinical cancer research : an official journal of the American Association for Cancer Research 20170110 14


<b>Purpose:</b> High-grade serous ovarian cancer (HGSOC) is an aggressive disease with few available targeted therapies. Despite high expression of estrogen receptor-alpha (ERα) in approximately 80% of HGSOC and some small but promising clinical trials of endocrine therapy, ERα has been understudied as a target in this disease. We sought to identify hormone-responsive, ERα-dependent HGSOC.<b>Experimental Design:</b> We characterized endocrine response in HGSOC cells across culture conditions [ t  ...[more]

Similar Datasets

2017-05-15 | GSE81612 | GEO
| S-EPMC3998833 | biostudies-literature
| S-EPMC6895927 | biostudies-literature
| S-EPMC3464279 | biostudies-literature
2015-04-03 | E-GEOD-65227 | biostudies-arrayexpress
| S-EPMC3206200 | biostudies-literature
| S-EPMC3244171 | biostudies-literature
| S-EPMC2593438 | biostudies-literature
| S-EPMC2698732 | biostudies-literature
| S-EPMC2268000 | biostudies-literature